1: Home (ALT-H)
2: HMA Joint (ALT-M)
3: Human Medicines (ALT-U)
- 3.1: Heads of Agencies (ALT-E)
- 3.2: CMDh (ALT-C)
- 3.3: MRI Product Index (ALT-R)
- 3.4: Directory (ALT-I)
4: Veterinary Medicines (ALT-V)

You are here: Human Medicines > Heads of Agencies > HMA Topics > Risk Management

3.1.1: About HMA (ALT-O)
3.1.2: HMA Topics (ALT-T)
- 3.1.2.1: Falsified Medicines (ALT-L)
- 3.1.2.2: Pharmacovigilance Activities (ALT-P)
- 3.1.2.3: Monitoring of Medicines for Human Use (ALT-N)
- 3.1.2.4: Risk Management (ALT-S)
- 3.1.2.5: Medicines for children
3.1.3: Stakeholder Information (ALT-K)
3.1.4: HMA Calendar
3.1.5: FAQ (ALT-Q)
3.1.6: Contact form
3.1.7: Contact points

RISK MANAGEMENT

European risk management strategy (ERMS): adopted work programme 2008-2009 (latest update: January 2008)
Click here

Further progress the European risk management strategy: rolling two-year work programme 2008-2009 (latest update: December 2007)
Click here

European risk management strategy: achievements to-date (latest upate: July 2007)
Click here

2008 Public Status Report on the Implementation of the European Risk Management Strategy (17 March 2009) (53.06 kb)

Overview of pharmacovigilance resources in Europe: survey of national competent authorities (latest update: February 2006)
Click here

Action plan to further progress the European risk management strategy rolling two-year work programme (mid 2005 - mid 2007) (latest update: February 2006)
Click here

European risk management strategy facilitation group, press release (December 2005)
Click here

Action plan to further progress the European risk management strategy (latest update: May 2005)
Click here

European risk management strategy: progress to-date and next steps (press release, May 2005)
Click here

Report of the ad-hoc working group on implementation of the European risk management strategy (ERMS) (May 2005)
Click here

Establishing a European risk management strategy: summary report of HoA ad-hoc working group (January 2003)
Click here